Divi’s Labs surges 4% as management remains confident of double-digit growth in FY25
Shares of Divi’s Labs witnessed a 3% surge as the management expressed confidence in achieving double-digit growth in FY25, following...
Divis labs
Stay updated with the latest news and articles about Divis labs.
Latest Articles
Profit for Divi Labs’ Q1 increased by 26% to Rs. 702 crores
Revenue from operations at Divis Laboratories increased by around 15% YoY to 2,254 crore.
Divi’s Lab go down by 5%: concerns over “unsustainable growth”
Stock has been downgraded to 'hold' from 'buy,' with the target price shrunk to Rs 4,250 from Rs 5,250 previously. Experts warned that the abnormal growth is unsustainable as the pandemic begins to fade globally.
Divi’s Laboratory share price hits high in 52-week post Q2 profit jump of 45.63%
On the account of robust sales, the drug firm Divi's Laboratory reported a rise in consolidated net profit of 45.63 percent to Rs. 519.59 crore for the second quarter.
Sensex reaches 42,500 mark and Nifty50 touches 12,451.80, records high
Post Democrat Joe Biden’s victory in the US Presidential Election 2020, the positive global cues have steered the Indian market on Monday.
Divi’s Lab’s net profit rises 45.6% Y-o-Y, rests at Rs 519.6 crore
The biggest driving factors behind the double-digit growth during the second quarter were the improved demand for Active Pharmaceutical Ingredient
Market Closing: Sensex, Nifty close with gains; Pharma stocks outperform
The Indian indices closed higher after rallying at good figures with Nifty crossing 11330 and Sensex crossing above 38400 on Monday.
Showing 15 of 469,299 articles